Damaune Journey

Damaune Journey serves as the Global Chief Growth Officer at 72andSunny since February 2021, focusing on business growth. Journey is also a board member at Juma Ventures and the AGB Foundation. Previously, Journey held roles including Chief Growth Officer at The Private Medical, Chief Development Officer (interim) at the National Action Council for Minorities in Engineering, and Chief Revenue Officer at Gavin de Becker & Associates. Notably, Journey was Vice President at ShotSpotter, Inc., contributing to the company's successful public offering, and director roles at CSECO involved significant global business expansion efforts. Early career experience includes positions at Eli Lilly as District Sales Manager and Manufacturing Plant Manager, and a stint as a Management Consultant at IBM. Educational credentials include an MBA in General Management from Harvard Business School and a BSE in Industrial Engineering from the University of Michigan. Additionally, Journey completed the Board Director Program at Harvard Business School Executive Education in 2022.